Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-39176203

ABSTRACT

High-risk human papillomavirus (HPV) infection is associated with cervical cancer while low-risk HPV strains mostly cause benign lesions. Multiple studies have also associated HPV with coronary artery (CAD) disease in women. Furthermore, the climacteric period in women, triggers chronic inflammation and has major implications for CAD and associated lipid disorders. The association of HPV with coronary artery disease in climacteric women has few studies, and the objective of this review is to gather and analyse scientific data on the subject. This is an integrative review performed on PubMed and Google Scholar using the keywords "HPV", "coronary heart disease" and "climacteric", among these keywords the boolean operator AND and the publication date filter. (2018 onwards). Five articles were found, whose main results show presence of high-risk vaginal HPV in climacteric women. Climacterium and HPV were associated with a three-fold increased risk of CAD, as well as with factors related to menopause that promote atheroma formation, lipid disorders and chronic inflammation. Thus, these results support the association between HPV infection and CAD in climacteric women, possibly via chronic inflammation, hormonal factors related to menopause and dyslipidemia.


Subject(s)
Menopause , Papillomavirus Infections , Humans , Female , Papillomavirus Infections/complications , Papillomavirus Infections/epidemiology , Coronary Artery Disease/epidemiology , Coronary Artery Disease/etiology , Coronary Disease/epidemiology , Coronary Disease/etiology
2.
Anticancer Res ; 41(8): 3707-3716, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34281829

ABSTRACT

BACKGROUND/AIM: Head-and-neck squamous cell carcinoma (HNSCC) is the fifth most common cancer in the world and human papillomavirus (HPV) is an important risk factor for this neoplasm. Recent studies showed an association between sex hormone receptors and pathogenesis and/or prognosis in patients with HNSCC. The aim of this study was to clarify the expression patterns of sex hormone receptors in HPV-positive and HPV-negative HNSCC and their associations with tumour biopathology and biological behaviour. MATERIALS AND METHODS: Scientific literature indexed in PubMed about sex hormone receptors in HNSCC was retrieved and critically analyzed, to obtain an overview of expression patterns and their possible implications for tumour biopathology and prognosis. RESULTS: Sex hormone receptors were more frequently detected in oropharyngeal tumours compared with HNSCC from other locations. ERα was associated with HPV-positive tumours. The androgen and progesterone receptors were associated with poor patient prognosis. Estrogen receptor alpha (ERα) is implicated in the biopathology of HNSCC in different ways, by promoting DNA hypermutation and facilitating HPV integration thus contributing to an immunogenic phenotype, but also by cooperating with the epithelial growth factor receptor (EGFR) to promote resistance to therapy. CONCLUSION: The expression of sex hormone receptors may be of prognostic value in specific tumour subgroups, but the use of hormonal therapies for HNSCC is still not in close sight.


Subject(s)
Head and Neck Neoplasms/virology , Papillomavirus Infections/complications , Receptors, Steroid/metabolism , Squamous Cell Carcinoma of Head and Neck/virology , Animals , Biomarkers, Tumor/metabolism , Female , Gonadal Steroid Hormones/metabolism , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/therapy , Humans , Male , Oropharyngeal Neoplasms/metabolism , Oropharyngeal Neoplasms/virology , Prognosis , Squamous Cell Carcinoma of Head and Neck/metabolism , Squamous Cell Carcinoma of Head and Neck/mortality , Squamous Cell Carcinoma of Head and Neck/therapy
3.
Sci Rep ; 10(1): 4073, 2020 03 05.
Article in English | MEDLINE | ID: mdl-32139801

ABSTRACT

Lipopolysaccharide (LPS) induces fever through cytokines like receptor-activator of nuclear factor κB ligand (RANKL), triggering mediators like prostaglandins (PG), endothelin-1 (ET-1), corticotrophin-releasing factor (CRF), substance P (SP) and endogenous opioids. LPS-induced fever is reduced in females compared with males except in ovariectomized (OVX) females which show increased fever mediated by PG. The present study aimed to identify the mediators involved in fever in intact and OVX female rats. Fever was induced with LPS (50 µg/kg) intraperitoneally or CRF (2.5 µg), ET-1 (1 pg), morphine (10 µg) and SP (500 ng) intracerebroventricularly in sham-operated and OVX rats. The role of RANKL was evaluated with osteoprotegerin (OPG, 1 µg, intracerebroventricularly). Expression of RANK, CRFI/II, ETB, µ-opioid (MOR) and NK1 receptors was evaluated by confocal microscopy. Besides LPS, only morphine induced fever in OVX rats while all mediators induced fever in sham-operated animals. OPG abolished LPS-induced fever in OVX but not sham-operated animals. Overall, fever involves similar central mediators in cycling females and males but only morphine induced fever in OVX females. Importantly, RANK/RANKL participates in LPS-induced fever in OVX females, as in males but not in cycling females.


Subject(s)
Cytokines/metabolism , Fever/etiology , Hypothalamus/immunology , Hypothalamus/metabolism , Lipopolysaccharides/toxicity , Ovariectomy/adverse effects , Analgesics, Opioid/metabolism , Animals , Corticotropin-Releasing Hormone/metabolism , Endothelin-1/metabolism , Female , Fever/metabolism , Fever/pathology , Hypothalamus/drug effects , Prostaglandins/metabolism , RANK Ligand/metabolism , Rats , Rats, Wistar , Substance P/metabolism
4.
PLoS One ; 14(9): e0222239, 2019.
Article in English | MEDLINE | ID: mdl-31509577

ABSTRACT

AIM: To investigate circulating hormonal, metabolic and inflammatory biomarker profiles in obese and non-obese middle-aged women. METHODS: A total of 110 women, aged 40-60 years, were included in this cross-sectional study. Patients were allocated, according to the occurrence of menopause and body mass index (BMI), into four groups: PM0 (premenopausal non-obese), PM1 (premenopausal obese), M0 (postmenopausal non-obese), and M1 (postmenopausal obese). Serum levels of gonadotropins, sex hormones, lipid markers, leptin, hs-CRP and interleukin-6 were obtained using either colorimetric or immunoenzymatic assays. Univariate and correlation analyses were performed among all clinical and laboratorial parameters. Principal component analysis was used to characterize subsets of biomarkers, which had their discriminatory capacity tested using discriminant function analysis. RESULTS: Levels of gonadotropins and female sex hormones were similar between PM0 and PM1 and between M0 and M1 (p > 0.05), all of them varied between PM0 and M0 (p < 0.05), but only estradiol was significantly altered in the comparison between PM1 and M1 (p = 0.027). Regarding metabolic markers, leptin was lower in PM0 than in M0 (p = 0.010) and higher in M1 than in M0 (p = 0.046). In premenopausal women, BMI correlated only to leptin, while it correlated to several other markers in postmenopausal women. A combination of FSH and leptin serum levels significantly discriminated the four groups (Wilks's lambda < 0.001, in canonical functions 1 and 2). CONCLUSION: A combined analysis of hormonal biomarkers may potentially distinguish obese from non-obese women with distinct menopause status. Further research is thus required to clarify the clinical significance of such findings.


Subject(s)
Menopause/metabolism , Obesity/metabolism , Biomarkers/blood , Body Mass Index , Brazil/epidemiology , C-Reactive Protein/analysis , Cross-Sectional Studies , Female , Gonadal Steroid Hormones/analysis , Gonadal Steroid Hormones/blood , Gonadotropins/analysis , Gonadotropins/blood , Humans , Interleukin-6/analysis , Interleukin-6/blood , Leptin/analysis , Leptin/blood , Lipids/analysis , Lipids/blood , Menopause/blood , Middle Aged , Obesity/physiopathology , Postmenopause/blood , Premenopause/blood
5.
ScientificWorldJournal ; 2019: 1872536, 2019.
Article in English | MEDLINE | ID: mdl-31320839

ABSTRACT

BACKGROUND: Cardiovascular diseases are leading causes of death worldwide. Recent studies suggest that infection by some viruses, including the human papillomavirus (HPV), may increase the risk of developing atheromatous lesions on coronary arteries. However, there is a lack of data regarding the possible association between HPV infection and coronary artery disease (CAD) in women. OBJECTIVE: To investigate whether HPV infection is associated with the occurrence of CAD among climacteric women. METHODS: The presence of CAD and cervical HPV DNA was investigated in 52 climacteric women. Social and demographic variables and metabolic profiles were also investigated. RESULTS: Among 27 women with CAD, 16 were positive for HPV, whereas 11 were negative. The presence of cervical HPV was strongly associated with CAD, after adjusting for demographic variables, health and sexual behaviors, comorbidities, and known cardiovascular risk factors. HPV-positive women showed a greater likelihood of having CAD (odds ratio [OR] = 3.74; 95% confidence interval [CI]: 1.16 to 11.96) as compared with HPV-negative women, particularly those infected with high-risk HPV types (OR = 4.90; 95% CI: 1.26 to 19.08). CONCLUSION: These results support the hypothesis that HPV infection might be associated with CAD among climacteric women, though further studies are needed to investigate the mechanisms involved.


Subject(s)
Climacteric , Coronary Artery Disease/epidemiology , Coronary Artery Disease/etiology , Papillomaviridae , Papillomavirus Infections/epidemiology , Adult , Age Factors , Aged , Female , Humans , Middle Aged , Odds Ratio , Papillomavirus Infections/complications , Papillomavirus Infections/virology , Public Health Surveillance , Risk Assessment , Risk Factors , Sex Factors , Socioeconomic Factors
6.
J Neuroimmunol ; 293: 1-7, 2016 Apr 15.
Article in English | MEDLINE | ID: mdl-27049554

ABSTRACT

Substance P (SP) is involved in fever that is induced by lipopolysaccharide (LPS) but not by interleukin-1ß or macrophage inflammatory protein-1α. Intracerebroventricular (i.c.v.) administration of the neurokinin-1 (NK1) receptor antagonist SR140333B in rats reduced fever that was induced by an i.c.v. injection of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), prostaglandin E2 (PGE2), corticotropin-releasing factor (CRF), endothelin-1 (ET-1), and morphine (MOR). Furthermore, an i.c.v. injection of SP induced a febrile response that was inhibited by indomethacin concomitant with an increase in PGE2 levels in cerebrospinal fluid. Lipopolysaccharide and PGE2 caused higher expression and internalization of NK1 receptors in the hypothalamus which were prevented by SR140333B. These data suggest that SP is an important mediator of fever, in which it induces a prostaglandin-dependent response and is released after TNF-α, IL-6, PGE2, CRF, endogenous opioids, and ET-1.


Subject(s)
Dinoprostone/cerebrospinal fluid , Fever/chemically induced , Fever/prevention & control , Pyrogens , Substance P/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Body Temperature/drug effects , Corticotropin-Releasing Hormone/pharmacology , Gene Expression Regulation/drug effects , Hypothalamus/drug effects , Hypothalamus/metabolism , Indomethacin/pharmacology , Interleukin-6/administration & dosage , Interleukin-6/metabolism , Male , Morphine/pharmacology , Polysaccharides/toxicity , Rats , Rats, Wistar , Receptors, Neurokinin-1/metabolism , Substance P/metabolism , Time Factors , Tropanes/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL